These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 18222349

  • 21. IgA glycosylation and immune complex formation in IgAN.
    Suzuki H, Novak J.
    Semin Immunopathol; 2021 Oct; 43(5):669-678. PubMed ID: 34570260
    [Abstract] [Full Text] [Related]

  • 22. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
    Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y.
    BMC Nephrol; 2014 Jun 13; 15():89. PubMed ID: 24928472
    [Abstract] [Full Text] [Related]

  • 23. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
    Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ.
    Nephrol Dial Transplant; 2011 Nov 13; 26(11):3451-7. PubMed ID: 21828345
    [Abstract] [Full Text] [Related]

  • 24. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct 13; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 25. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
    Suzuki Y, Suzuki H, Yasutake J, Tomino Y.
    Expert Opin Biol Ther; 2015 Apr 13; 15(4):583-93. PubMed ID: 25604055
    [Abstract] [Full Text] [Related]

  • 26. IgA nephropathy enigma.
    Mestecky J, Novak J, Moldoveanu Z, Raska M.
    Clin Immunol; 2016 Nov 13; 172():72-77. PubMed ID: 27444044
    [Abstract] [Full Text] [Related]

  • 27. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Nov 13; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 28. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Nov 13; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 29. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 30. Pathogenesis of IgA nephropathy.
    Lai KN.
    Nat Rev Nephrol; 2012 Mar 20; 8(5):275-83. PubMed ID: 22430056
    [Abstract] [Full Text] [Related]

  • 31. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M.
    J Am Soc Nephrol; 2022 May 20; 33(5):908-917. PubMed ID: 35115327
    [Abstract] [Full Text] [Related]

  • 32. Genetics and immunopathogenesis of IgA nephropathy.
    Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL.
    Clin Rev Allergy Immunol; 2011 Oct 20; 41(2):198-213. PubMed ID: 21188648
    [Abstract] [Full Text] [Related]

  • 33. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 20; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb 20; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb 20; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2008 Feb 20; 118(2):629-39. PubMed ID: 18172551
    [Abstract] [Full Text] [Related]

  • 40. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z, Zhang X, Han W, Yu G, Ying Z, Xu X, Wang M, Zhou X, Lv J, Zhang H.
    Int Immunopharmacol; 2021 Feb 20; 91():107282. PubMed ID: 33370682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.